Scopus BioPharma Inc. (SCPS)
OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
At close: Nov 9, 2026
Scopus BioPharma Market Cap
Scopus BioPharma has a market cap or net worth of $16.83 thousand as of November 9, 2026. It is the 51,716th most valuable company in the world and the 7,659th biggest in the United States.
Market Cap
16.83K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#7,659 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since December 16, 2020, Scopus BioPharma's market cap has decreased from 85.70M to 16.83K, a decrease of -99.98%. That is a compound annual growth rate of -76.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 16.83K | - |
| Dec 31, 2025 | 16.83K | 33.34% |
| Dec 31, 2024 | 12.63K | -99.30% |
| Dec 29, 2023 | 1.81M | -11.91% |
| Dec 30, 2022 | 2.06M | -94.04% |
| Dec 31, 2021 | 34.49M | -83.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Burzynski Research Institute | 26.29K |
| Ocean Biomedical | 23.24K |
| Biostax | 21.65K |
| Health Sciences Group | 20.51K |
| Bio-Path Holdings | 16.17K |
| Statera Biopharma | 14.52K |
| Scorpius Holdings | 12.23K |
| ObsEva | 11.72K |